Gingival-derived mesenchymal stem cell osteogenic differentiation (GMSC osteogenic differentiation)

Gingival-derived mesenchymal stem cell (GMSC) osteogenic differentiation is a complex biological process where multipotent stem cells isolated from the gingival lamina propria transition into functional, bone-forming osteoblasts (PMID: 31431849). This differentiation is orchestrated by a network of signaling pathways, most notably the Wnt/beta-catenin and BMP/Smad pathways, which trigger the expression of essential transcription factors like Runt-related transcription factor 2 (Runx2) and Osterix (PMID: 29754171). GMSCs are highly valued in regenerative medicine due to their easy accessibility, rapid proliferation, and potent immunomodulatory properties compared to bone marrow-derived MSCs (PMID: 21103061). In therapeutic contexts, this process is modulated using pharmacological inducers such as Dexamethasone or growth factors like BMP-2 to promote bone repair in periodontal disease and craniofacial defects (PMID: 25650473). While it holds significant promise for tissue engineering, clinical application requires careful monitoring to prevent complications such as ectopic mineralization or unwanted phenotypic shifts (PMID: 30251244).

Other names

GMSC osteogenesisOsteogenic differentiation of gingival mesenchymal stem cellsGingival stem cell bone formationGMSC-mediated mineralization

Activation of intracellular signaling pathways, including Wnt/beta-catenin, BMP/Smad, and MAPK/ERK, which upregulate the expression of master osteogenic transcription factors such as Runx2 and Osterix, leading to the production of mineralized extracellular matrix proteins.